ArticleACS omega2022
Improved Stable Drag Reduction of Controllable Laser-Patterned Superwetting Surfaces Containing Bioinspired Micro/Nanostructured Arrays.
Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 36 citations in OpenAlex.
- Ultrafast Laser-Induced Surface Texturing to Enhance Stainless Steel Gliding on Snow.Nanomaterials (Basel, Switzerland) · 2026Article
- Selective Deposition of Charged Droplets for Programmable and Rewritable Printing of Patterned Microstructure Arrays.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Fabrication and Drag Reduction Performance of Bionic Surfaces Featuring Staggered Shield Scale Structures.Biomimetics (Basel, Switzerland) · 2026Article
- Biomimetic Innovations: Exploring Bubble-Trapping Organisms for Manufacturing Breakthroughs.Biomimetics (Basel, Switzerland) · 2025Review
- Bionic research onRSC advances · 2022Article
- Preparation of a bionic lotus leaf microstructured surface and its drag reduction performance.RSC advances · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superwetting surfaces are widely used in many engineering fields for reducing energy and resistance loss. A facile and efficient method using laser etching has been used to fabricate and control superwettable drag reduction surfaces. Inspired by the self-cleaning theory of lotus leaves, we propose controllable patterned bionic superhydrophobic surfaces (BSSs) simulating the uneven micro/nanostructures of lotus leaves. The superhydrophobicity and drag reduction ratios at low velocities are highly improved using a laser ablation method on metal substrates. However, unstable air layers trapped on superhydrophobic surfaces are usually cut away by a high-velocity flow, which greatly reduces the drag reduction performance. The fabricated bionic superhydrophobic/hydrophilic surfaces (BSHSs) with alternated hydrophilic strips can build a large surface energy barrier to bind the three-phase contact line. It maintains the stable drag reduction by capturing the air bubbles attached to the hydrophilic strips at a high velocity. Three-dimensional simulation analysis and equipment to measure the weak friction of a self-assembled solid-liquid interface are used to explain the drag reduction mechanism and measure the drag reduction ratios at different flow speeds. BSSs achieve an improved drag reduction effect (maximum 52.76%) at a low velocity (maximum 1.5568 m/s). BSHSs maintain an improved and steady drag reduction effect at high speed. The drag reduction ratios can be maintained at about 30% at high speed, with a maximum value of 4.448 m/s. This research has broad application prospects in energy saving, liquid directional transportation, and shipping due to their robust superhydrophobic properties and stable drag reduction effect.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.